Trade name
Labetalol SXP
Presentation and preparation
5 mg/mL (volume: 10 mL)
IV administration
Bolus injection: Give undiluted over at least 2 minutes.
Continuous infusion: Dilute to 1 mg/mL or weaker.
Maximum concentration if necessary: 5 mg/mL undiluted via a central line only.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Labetalol 1 mg/mL or weaker:
Glucose 5%
Glucose 5% and sodium chloride 0.9%
Sodium chloride 0.9%
Additional information
Extravasation risk.
Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.
Patients should remain lying down during and for 3 hours after administration to minimise the risk of postural hypotension.
Taper the infusion slowly when discontinuing treatment; abrupt discontinuation may cause myocardial ischaemia.
Use immediately after dilution. Diluted solution is stable for 6 hours at room temperature.
Protect from light during storage.